Ann Arbor, MI13 Active Studies

Parkinsons Disease Clinical Trials in Ann Arbor, MI

Find 13 actively recruiting parkinsons disease clinical trials in Ann Arbor, MI. Connect with local research sites and explore new treatment options.

13
Active Trials
10
Sponsors
3,345
Enrolling

Recruiting Parkinsons Disease Studies in Ann Arbor

About Parkinsons Disease Clinical Trials in Ann Arbor

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 13 parkinsons disease clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 3,345 participants. Research is being sponsored by University of Massachusetts, Worcester, JHSPH Center for Clinical Trials, VA Office of Research and Development and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Ann Arbor — FAQ

Are there parkinsons disease clinical trials in Ann Arbor?

Yes, there are 13 parkinsons disease clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 13 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated September 2, 2026 from ClinicalTrials.gov